Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry.
Regeneron and Alnylam Team Up For NASH Fibrosis Drug
News: Recently, Regeneron (REGN) and Alnylam (ALNY) stated that they will team up and co-develop a drug to treat non-alcoholic steatohepatitis (NASH) fibrosis. The goal of the partnership is to....More>>>
Atara Biotherapeutics (NASDAQ:ATRA) had its price target decreased by Citigroup from $25.00 to $23.00 in a report released on Monday. Citigroup currently has a sell rating on the biotechnology company’s stock.
ATRA has been the subject of a number of other reports. JPMorgan Chase & Co. assumed coverage on Atara Biotherapeutics in a report on Tuesday, April 10th. They issued an overweight....More>>>
News articles about Foster Wheeler (NASDAQ:FWLT) have been trending somewhat positive recently, according to Accern. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Foster Wheeler....More>>>
Roche ADRs (OTCQX:RHHBY) remain in a downtrend even as the company has increased its guidance, following detailed but interim Q1 results (no EPS reported), to modest organic growth this year, but high-single-digit growth including the effects of last December’s US tax legislation. Coming into the important ASCO (oncology) meeting this weekend, this article provides an....More>>>
When biotech investors talk about the future of DNA sequencing, they inevitably focus on industry leader Illumina (NASDAQ:ILMN). But when biotech researchers talk about the future of DNA sequencing, the conversation almost always centers on privately held Oxford Nanopore Technologies, which is developing a new approach to reading genetic code called nanopore sequencing. The excitement isn’t....More>>>
Reata Pharmaceuticals (RETA) is a clinical-stage biotechnology company specializing in drugs that affect mitochondria-related diseases. Its lead candidate is for PAH (pulmonary arterial hypertension) resulting from connective tissue disease.
Reata came up in a screening I did of the new additions to the Nasdaq Biotechnology Index, which is used as a basis for the iShares Nasdaq Biotechnology....More>>>
Shares of Spark Therapeutics (NASDAQ:ONCE) have seen a nice bounce recently, having risen by 30% since late February. It looks like my “buy the dip” piece in late November was followed by a much larger “dip” than I was expecting (Note: This was an unexpected event and great example of how biotech is a minefield).
Figure 1: ONCE daily advanced chart (Source: Finviz....More>>>
The following stocks were moving the Manufacturing sector today.
Some of the biggest gainers among Manufacturing stocks include:
Diffusion Pharmaceuticals Inc (DFFN): DFFN stock is up 47.73% today. Kura Oncology Cmn (KURA): KURA stock is up 15.46% today. Modine Manufacturing Company (MOD): MOD stock is up 9.96% today. Stellar Biotch Cm ST (SBOT): SBOT stock is up 10.1% today. Aeglea....More>>>
I constantly see people rise in life who are not the smartest, sometimes not even the most diligent, but they are learning machines. They go to bed every night a little wiser than they were when they got up and boy does that help, particularly when you have a long run ahead of you. – Charlie Munger
Welcome to this edition of Integrated BioSci Rounds Report....More>>>
Kodak is moving from cameras to crypto in a move likely to be viewed as a picture-perfect example of bitcoin mania.
The century-old camera brand said Tuesday it is investing in blockchain technology and plans to launch a “photo-centric cryptocurrency” called KODAKCoin.
Kodak (KODK)’s stock surged as much as 125% in trading after the announcement.